Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Tdap Vaccination and Plasma Biomarkers of Alzheimer's Disease

NCT05183516 is registered in ClinicalTrials.gov with Mindful Diagnostics and Therapeutics, LLC as lead sponsor.

NCT NCT05183516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05183516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Tdap Vaccination and Plasma Biomarkers of Alzheimer's Disease
Lead sponsor
Mindful Diagnostics and Therapeutics, LLC
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 1, 2023
Completion date
March 31, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, late onset